ImmunityBio (IBRX) Goodwill (2024 - 2026)
ImmunityBio (IBRX) reported Goodwill of $910000.0 for Q1 2026, little changed year-over-year from $910000.0 in Q1 2025, and little changed on a QoQ basis from $910000.0 in Q4 2025.
ImmunityBio (IBRX) has 3 years of Goodwill data on file, last reported at $910000.0 in Q1 2026.
- Quarterly Goodwill changed 0.0% year-over-year to $910000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $910000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $910000.0, changed 0.0% from the prior year.
- Goodwill was little changed at $910000.0 in Q1 2026 per IBRX's latest filing, from $910000.0 in the prior quarter.
- Across five years, Goodwill topped out at $910000.0 in Q4 2024 and bottomed at $900000.0 in Q3 2024.
- The 3-year median for Goodwill is $910000.0 (2024), against an average of $908571.4.
- Peak annual rise in Goodwill reached 1.11% in 2025, while the deepest fall reached 0.0% in 2025.
- Tracing IBRX's Goodwill over 3 years: stood at $910000.0 in 2024, then changed by 0.0% to $910000.0 in 2025, then changed by 0.0% to $910000.0 in 2026.
- Per Business Quant, the three latest IBRX Goodwill figures stand at $910000.0 (Q1 2026), $910000.0 (Q4 2025), and $910000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 910,000.00 |
| Dec 31, 2025 | 910,000.00 |
| Sep 30, 2025 | 910,000.00 |
| Jun 30, 2025 | 910,000.00 |
| Mar 31, 2025 | 910,000.00 |
| Dec 31, 2024 | 910,000.00 |
| Sep 30, 2024 | 900,000.00 |